US 12377106
Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and for degrading BTK
granted A61KA61K31/497A61K31/506
Quick answer
US patent 12377106 (Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and for degrading BTK) held by NURIX THERAPEUTICS, INC. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NURIX THERAPEUTICS, INC.
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/497, A61K31/506, A61K31/5377, A61K9/0053